InvestorsHub Logo
Followers 307
Posts 11030
Boards Moderated 1
Alias Born 03/05/2009

Re: None

Tuesday, 05/27/2014 9:30:43 PM

Tuesday, May 27, 2014 9:30:43 PM

Post# of 10055
Very Very Interesting..... Puzzles pieces are falling into place.....

http://histalk2.com/2014/05/27/histalk-interviews-dave-dyell-svp-nanthealth/

Dr. Soon-Shiong has a far-reaching vision on personalized medicine and genomics. What are the steps required to take NantHealth to meet that vision?

We already have the genomic, the proteomic technology. What needs to be done now is taking that data and being able to map it in a meaningful way into the rest of the care process.

If you’re a case manager who’s looking at a care plan and walking your way through that on a member of your population that you’re trying to manage, and all of a sudden a physician orders a gene mapping and you get those results back, what do you do with that data? How do you map that wisdom that’s going to come back from the science into the overall decision support workflows that are going to be around traditional population health management to make it different?

We like to say it this way within NantHealth. What’s that one piece of data, that if we could get in front of a caregiver, would make for a significantly better outcome? That’s really what drives us all — trying to find that one piece of data, that one other piece of data that I could put in front of a physician, put in front of a caregiver, put in front of a scientist for that matter, that would give that patient a much better outcome.



BlackBerry seems to be on its last legs. Why did it suddenly get interested in healthcare and what will it co-develop with NantHealth?

That’s an interesting perspective, because one of the largest portions of the market that BlackBerry owned was healthcare. I don’t think I’ve walked into a hospital in 15 years that hadn’t had some form of BlackBerry technology there. The BlackBerry enterprise server is installed in hundreds of hospitals, if not thousands across the country, because of its secure messaging and because of HIPAA concerns and those things. People have been using BlackBerry for years.



They use BlackBerry devices, but this is actually developing healthcare-specific technologies and not just saying they’re going to park BlackBerry in a hospital.

It is, but that’s to me why it’s a natural foray for them. They’ve already go this large infrastructure. They’ve got a large customer base that’s already in healthcare that’s using one of their devices.

What they saw obviously with NantHealth is on our connectivity side again. Connectivity everywhere, regardless of where you are. We think the smartphone is another logical place to provide some of that connectivity. Not everybody’s going to want an Hbox in their home. A lot of us that are more tech-savvy are going to want our smartphone to be that.

Having the Nantoid with BlackBerry is going to be a really interesting play for us to be able to provide a device that’s optimized for that connectivity, optimized for image display, those types of things.

The NantHealth offering isn’t exclusive to BlackBerry, right?

No, of course not.



So their contribution is just to optimize it for BlackBerry?

Correct.



What are the milestones the market will see in the next few years from NantHealth?

I think what you’re going to see over the next few years is some significant growth within the telehealth side of the business as we continue to expand the connectivity-everywhere approach. You’re also going to see on the interoperability side us expand much more heavily into population health. We have some releases and stuff that will be coming out soon and new customers on that end where the Clinical Operating System is being used as the basis for multiple population health deals. These are again primarily focused around ACOs at this particular point





Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.